Milestone Scientific Inc.: Form 10-Q for the period ended Sep 30, 2016
Filed with the SEC on Nov 9, 2016 and accepted by EDGAR at Nov 9, 2016, 16:12 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-07-01 to 2016-09-30 | $3.2m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 9 months2016-01-01 to 2016-09-30 | $9.0m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months2016-07-01 to 2016-09-30 | $1.5m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months2016-01-01 to 2016-09-30 | $3.7m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2016-07-01 to 2016-09-30 | $1.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2016-01-01 to 2016-09-30 | $5.3m | us-gaap:GrossProfit |
| Research and development | 3 months2016-07-01 to 2016-09-30 | $303.3k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2016-01-01 to 2016-09-30 | $756.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2016-07-01 to 2016-09-30 | $2.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2016-01-01 to 2016-09-30 | $9.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2016-07-01 to 2016-09-30 | −$1.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2016-01-01 to 2016-09-30 | −$4.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2016-07-01 to 2016-09-30 | $846 | us-gaap:InterestExpense |
| Interest expense | 9 months2016-01-01 to 2016-09-30 | $2.8k | us-gaap:InterestExpense |
| Income tax | 3 months2016-07-01 to 2016-09-30 | $16.5k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2016-01-01 to 2016-09-30 | $80.1k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-07-01 to 2016-09-30 | −$1.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2016-01-01 to 2016-09-30 | −$4.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-07-01 to 2016-09-30 | −$0.05 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2016-01-01 to 2016-09-30 | −$0.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-07-01 to 2016-09-30 | −$0.05 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2016-01-01 to 2016-09-30 | −$0.16 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-07-01 to 2016-09-30 | 29,155,712 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2016-01-01 to 2016-09-30 | 25,965,566 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 9 months2016-01-01 to 2016-09-30 | $14.9k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2016-09-30 | $2.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-09-30 | $10.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-09-30 | $11.6m | us-gaap:Assets |
| Shareholders' equity | At period end2016-09-30 | $7.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-16-041564. Last ingested by Listed: Nov 14, 2026, 11:14 ET. Listed shows no prices and gives no investment advice.